- $161.09bn
- $212.59bn
- $62.58bn
Pfizer Inc - Pfizer Announces Completion of $13.5 Billion Debt Offering
AnnouncementPfizer Inc Pfizer Announces Settlement And License Agreement With Mylan Related
AnnouncementPfizer Inc - Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ra
AnnouncementPfizer Inc - Pfizer invite for Jan 22 analyst meeting
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Jean-Paul Valles Leaves Pfizer Board of Directors
AnnouncementPfizer Inc New Pfizer Data Helps to Identify
AnnouncementPfizer Inc - Pfizer to Return Indiplon Worldwide Rights to Neurocrine
AnnouncementPfizer Inc - Dividend Declaration
AnnouncementPfizer Inc - Repatriation
AnnouncementPfizer Inc - Governance
AnnouncementPfizer Inc - Dividend Declaration
AnnouncementPfizer Inc - Regulatory Approval - Product Approval
AnnouncementPfizer Inc - Pfizer Declares a 29-cent Third-Quarter, 2007, Dividend
AnnouncementPfizer Inc - Pfizer Board of Directors to Initiate Face-to-Face Meetings with Co
AnnouncementPfizer Inc - Pfizer Statement on Patent Office Communication
AnnouncementPfizer Inc Pfizer Receives Approval from Chinas Ministry of Commerce for Pendin
AnnouncementPfizer Inc - Research Update
Announcement